| Title | Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA. |
| Publication Type | Journal Article |
| Year of Publication | 2011 |
| Authors | Hsu, H. E., C. E. Rydzak, K. L. Cotich, B. Wang, P. E. Sax, E. Losina, K. A. Freedberg, S. J. Goldie, Z. Lu, and R. P. Walensky |
| Corporate Authors | CEPAC Investigators |
| Journal | HIV medicine |
| Volume | 12 |
| Issue | 2 |
| Pagination | 97-108 |
| Date Published | 2011 Feb |
| ISSN | 1468-1293 |
| Keywords | Abnormalities, Drug-Induced, Adult, Anti-HIV Agents, Benzoxazines, Female, HIV Infections, Humans, Life Expectancy, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Risk Assessment, Risk Factors, Teratogens, United States |
| Abstract | The aim of the study was to quantify the benefits (life expectancy gains) and risks (efavirenz-related teratogenicity) associated with using efavirenz in HIV-infected women of childbearing age in the USA. |
| DOI | 10.1111/j.1524-4733.2010.00763.x |
| Alternate Journal | HIV Med. |
